Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus)

Autor: Rahman, Anisur, Lamberty, Yves, Schenker, Esther, Cella, Massimo, Languille, Solène, Bordet, Régis, Richardson, Jill, Pifferi, Fabien, Aujard, Fabienne
Přispěvatelé: Mécanismes Adaptatifs et Evolution (MECADEV), Muséum national d'Histoire naturelle (MNHN)-Centre National de la Recherche Scientifique (CNRS), UCB Pharma S.A.[Braine-l'Alleud], Institut de Recherches SERVIER (IRS), Chiesi Farmaceutici, Université Lille Nord de France (COMUE), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), GlaxoSmithKline, Glaxo Smith Kline, This work was financially supported as part of the Pharma-Cog consortium by the European Community’s Seventh Framework Programme for the Innovative Medicine Initiative under Grant Agreement no. 115009., UCB Pharma [Brussels], Aujard, Fabienne
Rok vydání: 2017
Předmět:
Male
Aging
MESH: Aging/drug effects
lcsh:Medicine
Cognition
Learning and Memory
Piperidines
Medicine and Health Sciences
MESH: Animals
Donepezil
lcsh:Science
Spatial Memory
Animal Management
Cognitive Impairment
Mammals
Cognitive Neurology
MESH: Sleep Deprivation/physiopathology
Neurodegenerative Diseases
Agriculture
Animal Models
MESH: Alzheimer Disease/physiopathology
Neurology
Experimental Organism Systems
Indans
Vertebrates
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
MESH: Cheirogaleidae
Cheirogaleidae
MESH: Sleep Deprivation/complications
Research Article
MESH: Memory Disorders/etiology
Primates
Lemurs
MESH: Sleep Deprivation/drug therapy
Cognitive Neuroscience
Prosimians
Mouse Models
Research and Analysis Methods
Model Organisms
MESH: Spatial Memory/drug effects
Alzheimer Disease
Memantine
Memory
Mental Health and Psychiatry
Animals
MESH: Alzheimer Disease/drug therapy
[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
MESH: Alzheimer Disease/complications
MESH: Donepezil
Memory Disorders
Animal Performance
MESH: Memory Disorders/physiopathology
lcsh:R
MESH: Memantine/pharmacology
Organisms
Biology and Life Sciences
Animal Cognition
MESH: Male
MESH: Memory Disorders/drug therapy
Disease Models
Animal

MESH: Piperidines/pharmacology
Amniotes
Sleep Deprivation
Cognitive Science
lcsh:Q
MESH: Indans/pharmacology
Dementia
MESH: Disease Models
Animal

Zoology
Neuroscience
Zdroj: PLoS ONE
PLoS ONE, Public Library of Science, 2017, 12 (9), pp.e0184822. ⟨10.1371/journal.pone.0184822⟩
PLoS ONE, Vol 12, Iss 9, p e0184822 (2017)
PLoS ONE, 2017, 12 (9), pp.e0184822. ⟨10.1371/journal.pone.0184822⟩
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0184822⟩
Popis: International audience; The development of novel therapeutics to prevent cognitive decline of Alzheimer's disease (AD) is facing paramount difficulties since the translational efficacy of rodent models did not resulted in better clinical results. Currently approved treatments, including the acetylcholinesterase inhibitor donepezil (DON) and the N-methyl-D-aspartate antagonist memantine (MEM) provide marginal therapeutic benefits to AD patients. There is an urgent need to develop a predictive animal model that is phylogenetically proximal to humans to achieve better translation. The non-human primate grey mouse lemur (Microcebus murinus) is increasingly used in aging research, but there is no published results related to the impact of known pharmacological treatments on age-related cognitive impairment observed in this primate. In the present study we investigated the effects of DON and MEM on sleep-deprivation (SD)-induced memory impairment in young and aged male mouse lemurs. In particular, spatial memory impairment was evaluated using a circular platform task after 8 h of total SD. Acute single doses of DON or MEM (0.1 and 1mg/kg) or vehicle were administered intraperitoneally 3 h before the cognitive task during the SD procedure. Results indicated that both doses of DON were able to prevent the SD-induced deficits in retrieval of spatial memory as compared to vehicle-treated animals, both in young and aged animals Likewise, MEM show a similar profile at 1 mg/kg but not at 0.1mg/kg. Taken together, these results indicate that two widely used drugs for mitigating cognitive deficits in AD were partially effective in sleep deprived mouse lemurs, which further support the translational potential of this animal model. Our findings demonstrate the utility of this primate model for further testing cognitive enhancing drugs in development for AD or other neuropsychiatric conditions.
Databáze: OpenAIRE